D
SELLAS Life Sciences Group, Inc. SLS
$1.91 $0.09235.07% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -13.56% 13.72% 5.22% 4.85% 21.91%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -0.31% 25.14% 0.58% 9.75% -23.13%
Change in Net Operating Assets 64.72% -317.18% 22.94% 54.69% -48.37%
Cash from Operations 19.18% -26.80% 8.37% 19.38% 10.03%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -82.06% 32,651.39% -99.63% 4,656.04% -98.45%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -82.06% 294,662.50% -99.96% 4,656.04% -98.45%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -121.36% 303.09% -160.12% 228.23% -158.34%